We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1451
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$4.24M 0.01%
9,885
BF.A icon
1452
Brown-Forman Class A
BF.A
$13.3B
$4.23M 0.01%
67,554
-49,276
-42% -$3.29M
PLAY icon
1453
Dave & Buster's
PLAY
$357M
$4.21M 0.01%
109,726
-31,714
-22% -$1.15M
SCCO icon
1454
Southern Copper
SCCO
$166B
$4.21M 0.01%
80,809
-5,253
-6% -$304K
HGV icon
1455
Hilton Grand Vacations
HGV
$3.55B
$4.19M 0.01%
88,063
+1,479
+2% +$62.6K
MTRN icon
1456
Materion
MTRN
$6.04B
$4.18M 0.01%
60,857
-7,913
-12% -$566K
OXM icon
1457
Oxford Industries
OXM
$552M
$4.17M 0.01%
46,258
-7,703
-14% -$701K
MRVI icon
1458
Maravai LifeSciences
MRVI
$919M
$4.16M 0.01%
84,851
+17,298
+26% +$844K
ASO icon
1459
Academy Sports + Outdoors
ASO
$2.98B
$4.14M 0.01%
103,559
+18,562
+22% +$740K
AWI icon
1460
Armstrong World Industries
AWI
$7.84B
$4.14M 0.01%
43,401
-2,136
-5% -$224K
MLAB icon
1461
Mesa Laboratories
MLAB
$574M
$4.14M 0.01%
13,688
-1,431
-9% -$407K
PLUS icon
1462
ePlus
PLUS
$2.34B
$4.14M 0.01%
80,638
-10,802
-12% -$534K
ATKR icon
1463
Atkore
ATKR
$3.16B
$4.13M 0.01%
47,537
-935
-2% -$77.8K
LAZ icon
1464
Lazard
LAZ
$4.31B
$4.13M 0.01%
90,184
-8,800
-9% -$411K
UIS icon
1465
Unisys
UIS
$217M
$4.13M 0.01%
164,231
-25,213
-13% -$596K
TREE icon
1466
LendingTree
TREE
$451M
$4.13M 0.01%
29,510
+654
+2% +$115K
FBNC icon
1467
First Bancorp
FBNC
$2.68B
$4.11M 0.01%
95,438
-3,997
-4% -$163K
OII icon
1468
Oceaneering
OII
$4.77B
$4.1M 0.01%
307,728
-38,146
-11% -$497K
AUB icon
1469
Atlantic Union Bankshares
AUB
$5.97B
$4.09M 0.01%
111,056
+326
+0.3% +$11.7K
IPAR icon
1470
Interparfums
IPAR
$3.94B
$4.08M 0.01%
54,628
-6,907
-11% -$505K
VRNT
1471
DELISTED
Verint Systems
VRNT
$4.08M 0.01%
91,059
-6,649
-7% -$289K
FCF icon
1472
First Commonwealth Financial
FCF
$2.17B
$4.08M 0.01%
299,107
-35,601
-11% -$474K
HLF icon
1473
Herbalife
HLF
$1.29B
$4.08M 0.01%
96,180
-7,972
-8% -$394K
BIG
1474
DELISTED
Big Lots, Inc.
BIG
$4.08M 0.01%
93,978
-9,961
-10% -$542K
KRA
1475
DELISTED
Kraton Corporation
KRA
$4.07M 0.01%
89,196
-12,432
-12% -$494K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.